Godfrey Phillips India (500163) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
19 Nov, 2025Executive summary
Consolidated gross sales value reached Rs 10,626 crore for 9M FY25, up 25% year-over-year; net profit before exceptional items at Rs 837 crore, also up 25% year-over-year.
Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, were approved and reviewed by the Board and Audit Committee on February 13, 2025.
Statutory auditors conducted a limited review and found no material misstatements in the financial statements.
Robust domestic cigarette volume growth and strong unmanufactured tobacco exports (Rs 1,411 crore) supported topline.
Certified as 'Great Place To Work' for the sixth consecutive year; focus on sustainability and young leadership.
Financial highlights
Standalone revenue from operations for Q3 FY25 was ₹189,675 lakhs, up from ₹148,211 lakhs in Q3 FY24; nine-month revenue was ₹498,001 lakhs, up from ₹409,970 lakhs year-over-year.
Standalone net profit for Q3 FY25 was ₹33,233 lakhs, compared to ₹24,555 lakhs in Q3 FY24; nine-month net profit was ₹80,247 lakhs, up from ₹70,242 lakhs year-over-year.
Gross profit for 9M FY25 at Rs 1,755 crore; gross profit margin at 16.5%.
Q3 FY25 gross sales value at Rs 3,958 crore, up 29.2% year-over-year; net revenue at Rs 1,592 crore, up 27.4% year-over-year.
Interim dividend of Rs 35 per share (₹35 per equity share) declared and paid for FY25.
Outlook and guidance
Plans to enter new markets and launch new offerings underway.
Focus on sustaining growth momentum, strengthening core business, and expanding international presence.
Strategic partnership with Philip Morris International to continue for Marlboro brand in India.
The company is in the process of closing its Retail Business Division (24Seven), with management reassessing the exceptional loss and closure costs as reasonable.
Latest events from Godfrey Phillips India
- Gross sales and net profit surged, with bonus shares, dividend, and insurance claim for fire loss.500163
Q3 25/2630 Jan 2026 - Double-digit sales growth and tobacco strength offset by retail exit loss and leadership changes.500163
Q1 24/2519 Nov 2025 - Strong profit growth from tobacco, retail exit costs, new ESPS, and leadership changes.500163
Q2 24/2519 Nov 2025 - Sales and profit surged, Rs. 17 interim dividend and 2:1 bonus shares issued.500163
Q2 25/2610 Nov 2025 - Strong profit growth, 2:1 bonus share issue, and robust tobacco segment performance.500163
Q1 25/268 Aug 2025 - Gross sales rose 34%, net profit up 21%, and retail business exited; Rs 95/share dividend.500163
Q4 24/256 Jun 2025